Karima Chaoui

Dr. Karima Chaoui


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Proteomics
Verified
Journal Article
Closed access
CRClaire Ramus
Claire Ramus
AHAgnes Hovasse
Agnes Hovasse
MMMarlène Marcellin
Marlène Marcellin
AHAnne-Marie HESSE
Anne-Marie HESSE
EMEmmanuelle Mouton-Barbosa
Emmanuelle Mouton-Barbosa
APAnne Gonzalez de Peredo
Anne Gonzalez de Peredo

21 December 2006 in Proteome Science
Verified
Journal Article
Open access
JNJérémie Neasta
Jérémie Neasta
SUSandrine Uttenweiler-Joseph
Sandrine Uttenweiler-Joseph
KCKarima Chaoui
Karima Chaoui
BMBernard Monsarrat
Bernard Monsarrat
JMJean-Claude Meunier
Jean-Claude Meunier
LMLionel Moulédous
Lionel Moulédous
Background: Opiate addiction reflects plastic changes that endurably alter synaptic transmission within relevant neuronal circuits. The biochemical mechanisms of these adaptations remain largely unknown and proteomics-based approaches could lead to a broad characterization of the molecular events underlying adaptations to chronic drug exposure. Results: Thus, we have started proteomic analyses of the effects of chronic morphine exposure in a recombinant human neuroblastoma SH-SY5Y clone that stably overexpresses the μ-opioid receptor. Cells were treated with morphine for 6, 24 and 72 hours, the proteins were separated by 2-D gel electrophoresis and stained with Coomassie blue, and the protein map was compared with that obtained from untreated cells. Spots showing a statistically significant variation were selected for identification using mass spectrometric analyses. Conclusion: A total of 45 proteins were identified, including proteins involved in cellular metabolism, cytoskeleton organization, vesicular trafficking, transcriptional and translational regulation, and cell signaling.

19 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
CACamille Attané
Camille Attané
DEDavid Estève
David Estève
KCKarima Chaoui
Karima Chaoui
JIJason S Iacovoni
Jason S Iacovoni
Jill CorreJill Corre
Jill Corre
CMCatherine Muller
Catherine Muller
During energy demanding conditions, white adipocytes store triglycerides and release fatty acids through lipolysis. In contrast, bone marrow adipocytes (BM-Ad) increase in size during caloric restriction, suggesting this fat depot exhibits precise metabolic specificity. We found subcutaneous adipocytes (SC-Ad) and BM-Ad share morphological features, but possess distinct lipid metabolism. BM-Ad show enrichment in cholesterol-oriented metabolism that correlates with increased free cholesterol content, while proteins involved in lipolysis were downregulated. A strong down-regulation in expression of monoacylglycerol (MG) lipase was observed leading to an accumulation of major MG species and accordingly the basal and induced lipolytic responses were absent in BM-Ad. These features are not recapitulated in vitro using differentiated bone marrow mesenchymal stem cells. Since our data demonstrate that BM-Ad comprise a distinct class of adipocytes, we propose renaming them yellow adipocytes.

28 November 2024 in Cells
Verified
Journal Article
Open access
PDF file
CGClémence Guillon
Clémence Guillon
CPCarole Pichereaux
Carole Pichereaux
ILIkrame Lazar
Ikrame Lazar
KCKarima Chaoui
Karima Chaoui
EBEmmanuelle Mouton Barbosa
Emmanuelle Mouton Barbosa
BFBertrand Fabre
Bertrand Fabre
The identification of small proteins and proteins produced from unannotated open reading frames (called alternative proteins or AltProts) has changed our vision of the proteome and has attracted more and more attention from the scientific community. Despite several studies investigating particular AltProts in diseases and demonstrating their importance in such context, we are still missing data on their expression and functions in many pathologies. Among these, pancreatic ductal adenocarcinoma (PDAC) is a particularly relevant case to study alternative proteins. Indeed, late detection of this disease, notably due to the lack of reliable biomarkers of early-stage PDAC, and the fact that tumors rapidly develop resistance to most of the treatments used in the clinics warrant the exploration of new repertoires of molecules. In the present article, we aim to investigate the alternative proteome of pancreatic cancer cell lines as a first attempt to decipher the expression of AltProts in PDAC. Thanks to a combined data-dependent and data-independent acquisition mass spectrometry workflow, we were able to identify tryptic peptides matching 113 AltProts in a panel of 6 cell lines. In addition, we identified AltProts differentially expressed between pancreatic cancer cell lines and other cells (HeLa and HEK293T). Finally, mining the TCGA and Gtex databases showed that the corresponding transcripts encoding several AltProts we identified are differentially expressed between PDAC tumors and normal tissues and are correlated with the patient’s survival.